Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bill Sibold
Pharma
Sanofi shakes up leadership, says goodbye to specialty care head
Bill Sibold, who took over the company's specialty care unit in 2017 just after Dupixent's first approval, is leaving Sanofi effective immediately.
Zoey Becker
Aug 31, 2023 11:14am
Sanofi's Dupixent still 'at the beginning' of its journey: exec
Apr 28, 2022 11:37am
Sanofi inks massive Boston lease to house 2,700 employees
Dec 18, 2018 11:30am
Sanofi, Regeneron sock $1B-plus into new meds, Dupixent included
Jan 8, 2018 11:15am
Sanofi's Dupixent clears payer hurdles as scripts ramp up
Jul 31, 2017 10:48am
NICE backflips on Sanofi's Gaucher med Cerdelga
Jun 1, 2017 9:32am
